Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Pakistan Deploys Paramilitary Force to Secure Strategic CopperGold Belt Americans Feel Inflation Squeeze Ahead of Memorial Day Weekend Travel Food Costs Surge Lamborghini CEO Defends EV Cancellation Amid Ferrari Backlash General Motors Expands EV Lineup with Cadillac Vistiq Targeting 300Mile Range 3M India Reports 202 Q4 Profit Surge and Declares 506 Per Share Dividend Including Special Payout NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline NGS Q1 2026 Earnings EPS Beats Estimates by 175 on Operational Strength MLM Q1 2026 Earnings Slight EPS Miss Amid Solid Aggregate Demand Westport Fuel Systems WPRT Q1 2026 Earnings EPS Exceeds Expectations Amid Revenue Uncertainty Stock Declines SHIM Q1 2026 Earnings EPS Misses Estimates as Stock Declines Sharply Driven Brands Holds Steady Near Support Amid Modest Decline Starbucks SBUX Edges Lower as Traders Weigh Support and Resistance Dynamics Entergy Mississippi Bonds EMP Edge Higher as Income Seekers Return Globalstar Inc GSAT Edges Higher as Satellite Communications Sector Attracts Renewed Interest DeepSeek AI Chinese Startup Claims CostEffective HighPerformance Models Without Advanced Chips US Prioritizes American AI Integration in Asia Following TrumpXi Summit Vegorama Punjabi Angithi IPO Allotment Likely Today After 35x Oversubscription South KoreaNetherlands Chip Alliance Extends Beyond ASML Collaboration The Bank of New York Mellon BK Q1 2026 Earnings EPS Surpasses Expectations Amid Stable Operations CLIR Q1 2026 Earnings WiderthanExpected Loss Reflects Continued PreRevenue Development BNGO Q1 2026 Earnings NarrowerthanExpected Loss Bolsters Investor Confidence Peoples Financial Services Corp Q1 2026 Earnings EPS Misses Estimates by 795 Stock Declines CMTG Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Mortgage Market Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues